Identifying ovarian cancer specific targeted drugs using high-throughput drug sensitivity profiles of primary cancer cells

Astrid Murumagi; Akira Hirasawa; Suleiman Khan; Daniela Ungureanu; Mariliina Arjama; Teijo Pellinen; Samuli Eldfors; Riitta Koivisto-Korander; Arto Leminen; Ralf Butzow; Tero Aittokallio; Olli Kallioniemi

doi:10.1158/1538-7445.AM2017-410

Identifying ovarian cancer specific targeted drugs using high-throughput drug sensitivity profiles of primary cancer cells

Astrid Murumagi, Akira Hirasawa, Suleiman Khan, Daniela Ungureanu, Mariliina Arjama, Teijo Pellinen, Samuli Eldfors, Riitta Koivisto-Korander, Arto Leminen, Ralf Butzow, Tero Aittokallio, Olli Kallioniemi

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	410
Journal	Cancer Research
Volume	77
Issue number	Supplement 13
Number of pages	2
ISSN	0008-5472
DOIs	https://doi.org/10.1158/1538-7445.AM2017-410
Publication status	Published - Jul 2017
MoE publication type	Not Eligible
Event	Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Washington Duration: 1 Apr 2017 → 5 Apr 2017

Access to Document

10.1158/1538-7445.AM2017-410

Cite this

Murumagi, A., Hirasawa, A., Khan, S., Ungureanu, D., Arjama, M., Pellinen, T., Eldfors, S., Koivisto-Korander, R., Leminen, A., Butzow, R., Aittokallio, T., & Kallioniemi, O. (2017). Identifying ovarian cancer specific targeted drugs using high-throughput drug sensitivity profiles of primary cancer cells. Cancer Research, 77(Supplement 13), Article 410. https://doi.org/10.1158/1538-7445.AM2017-410

@article{881e7da10c864c888fef39c073df2dc6,

title = "Identifying ovarian cancer specific targeted drugs using high-throughput drug sensitivity profiles of primary cancer cells",

author = "Astrid Murumagi and Akira Hirasawa and Suleiman Khan and Daniela Ungureanu and Mariliina Arjama and Teijo Pellinen and Samuli Eldfors and Riitta Koivisto-Korander and Arto Leminen and Ralf Butzow and Tero Aittokallio and Olli Kallioniemi",

year = "2017",

month = jul,

doi = "10.1158/1538-7445.AM2017-410",

language = "English",

volume = "77",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "Supplement 13",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR) ; Conference date: 01-04-2017 Through 05-04-2017",

}

Murumagi, A, Hirasawa, A, Khan, S , Ungureanu, D , Arjama, M , Pellinen, T, Eldfors, S, Koivisto-Korander, R, Leminen, A , Butzow, R , Aittokallio, T & Kallioniemi, O 2017, 'Identifying ovarian cancer specific targeted drugs using high-throughput drug sensitivity profiles of primary cancer cells', Cancer Research, vol. 77, no. Supplement 13, 410. https://doi.org/10.1158/1538-7445.AM2017-410

TY - JOUR

T1 - Identifying ovarian cancer specific targeted drugs using high-throughput drug sensitivity profiles of primary cancer cells

AU - Murumagi, Astrid

AU - Hirasawa, Akira

AU - Khan, Suleiman

AU - Ungureanu, Daniela

AU - Arjama, Mariliina

AU - Pellinen, Teijo

AU - Eldfors, Samuli

AU - Koivisto-Korander, Riitta

AU - Leminen, Arto

AU - Butzow, Ralf

AU - Aittokallio, Tero

AU - Kallioniemi, Olli

PY - 2017/7

Y1 - 2017/7

U2 - 10.1158/1538-7445.AM2017-410

DO - 10.1158/1538-7445.AM2017-410

M3 - Meeting Abstract

SN - 0008-5472

VL - 77

JO - Cancer Research

JF - Cancer Research

IS - Supplement 13

M1 - 410

T2 - Annual Meeting of the American-Association-for-Cancer-Research (AACR)

Y2 - 1 April 2017 through 5 April 2017

ER -